Exploring the action mechanism of Gegensan in the treatment of alcoholic liver disease based on network pharmacology and bioinformatics

被引:1
|
作者
Yang, Jiakai [1 ]
Zhuang, Qianqian [1 ]
Tang, Ke [1 ]
Liu, Xinli [1 ]
机构
[1] Qilu Univ Technol, Dept Biol Engn, Jinan 250303, Shandong, Peoples R China
基金
中国国家自然科学基金;
关键词
alcoholic liver disease; differential analysis; Gegensan; molecular docking; network pharmacology; TRADITIONAL CHINESE MEDICINE; FATTY LIVER; PROTEIN; INFORMATION; ACTIVATION; FIBROSIS; DATABASE;
D O I
10.1097/MD.0000000000038315
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Gegensan (GGS) has been reported for the treatment of alcoholic liver disease (ALD), but its therapeutic mechanism is still unclear. This paper aims to determine the therapeutic mechanism and targets of action of GGS on alcoholic liver disease utilizing network pharmacology and bioinformatics. The active ingredients in GGS were screened in the literature and databases, and common targets of ALD were then obtained from public databases to construct the network diagram of traditional Chinese medicine-active ingredient targets. Based on the common targets, Gene Ontology enrichment analysis and Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis were performed to find target enrichment pathways, and the core targets were screened out by combining differential analysis and protein-protein interaction network analysis. Molecular docking was performed to verify the binding effect between the core targets and the corresponding active ingredients. ALD and GGS have 84 common targets, corresponding to 91 active ingredients. After subsequent differential analysis and protein-protein interaction network analysis, 10 core targets were identified. Gene Ontology and KEGG enrichment analyses showed that the main BPs corresponding to the common targets included the response to lipopolysaccharide, inflammatory response, etc. The KEGG pathways involved in the regulation of the common targets included the lipid-atherosclerosis pathway and the alcoholic liver disease pathway, etc. Further molecular docking showed that the core targets CYP1A1, CYP1A2, CXCL8, ADH1C, MMP1, SERPINE1, COL1A1, APOB, MMP1, and their corresponding 4 active ingredients, Naringenin, Kaempferol, Quercetin, and Stigmasterol, have a greater docking potential. The above results suggest that GGS can regulate lipid metabolism and inflammatory response in the ALD process, and alleviate the lipid accumulation and oxidative stress caused by ethanol. This study analyzed the core targets and mechanisms of action of GGS on ALD, which provides certain theoretical support for the further development of GGS in the treatment of ALD, and provides a reference for the subsequent research on the treatment of ALD.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Exploring the Mechanism of Action of Sea Buckthorn in the Treatment of Alcoholic Liver Injury Based on Network Pharmacology
    Deng B.
    Chen J.
    Li X.
    Lou K.
    Zhou L.
    Zhou Y.
    Xiao Z.
    Science and Technology of Food Industry, 2024, 45 (14) : 25 - 33
  • [2] EXPLORING THE MECHANISM OF ACTION OF GINSENG IN THE TREATMENT OF HEPATOCELLULAR CARCINOMA BASED ON NETWORK PHARMACOLOGY
    Zhou, Zhaoru
    Yu, Jingyun
    Ji, Haiwei
    Sheng, Jinjin
    Ling, Rong
    Wang, Haotian
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2023, 19 : 8 - 8
  • [3] Exploring the molecular mechanism of Xuebifang in the treatment of diabetic peripheral neuropathy based on bioinformatics and network pharmacology
    Hu, Faquan
    Lin, Jiaran
    Xiong, Liyuan
    Li, Zhengpin
    Liu, Wen-ke
    Zheng, Yu-jiao
    FRONTIERS IN ENDOCRINOLOGY, 2024, 15
  • [4] Mechanism of Phellodendron and Anemarrhena Drug Pair on the Treatment of Liver Cancer Based on Network Pharmacology and Bioinformatics
    Ruan, Xiaofeng
    Li, Wenyuan
    Du, Peng
    Wang, Yao
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [5] Exploring the mechanism of action of herbal compounding in the treatment of myasthenia gravis based on network pharmacology
    Liu, XiaoMing
    Kuang, YingYan
    Bian, CaiRu
    Hu, ShaoWen
    Xie, YuanFang
    Zhao, BeiBei
    Jin, YuanLin
    BIOTECHNOLOGY AND GENETIC ENGINEERING REVIEWS, 2024, 40 (02) : 1164 - 1179
  • [6] Exploring the Mechanism of Sempervirine Inhibiting Glioblastoma Invasion Based on Network Pharmacology and Bioinformatics
    Zhang, Bingqiang
    Wang, Wenyi
    Song, Yu
    Chen, Huixian
    Lin, Xinxin
    Chen, Jingjing
    Chen, Ying
    Huang, Jinfang
    Li, Desen
    Wu, Shuisheng
    PHARMACEUTICALS, 2024, 17 (10)
  • [7] Exploring the mechanism and experimental verification of puerarin in the treatment of endometrial carcinoma based on network pharmacology and bioinformatics analysis
    Zhiheng Lin
    Xiaohui Sui
    Wenjian Jiao
    Ying Wang
    Junde Zhao
    BMC Complementary Medicine and Therapies, 22
  • [8] Exploring the mechanism and experimental verification of puerarin in the treatment of endometrial carcinoma based on network pharmacology and bioinformatics analysis
    Lin, Zhiheng
    Sui, Xiaohui
    Jiao, Wenjian
    Wang, Ying
    Zhao, Junde
    BMC COMPLEMENTARY MEDICINE AND THERAPIES, 2022, 22 (01)
  • [9] Exploring the mechanism of action of acupuncture in the treatment of sciatica based on bioinformatics
    Tang, Dianfeng
    Liu, Tao
    Fan, Jiajia
    PROCEEDINGS OF 2023 4TH INTERNATIONAL SYMPOSIUM ON ARTIFICIAL INTELLIGENCE FOR MEDICINE SCIENCE, ISAIMS 2023, 2023, : 1152 - 1156
  • [10] Mechanism of Xing 9 ling tablet candy for alcoholic liver disease based on network pharmacology
    Zhao, Xiaomei
    Qu, Qiong
    Zhang, Ying
    Zhao, Peiyuan
    Zhang, Xinbo
    Tang, Yingying
    Lei, Xuan
    Wei, Xuan
    Song, Xiao
    ANALYTICAL BIOCHEMISTRY, 2024, 691